Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease.
about
Combined inhibition of TGFβ and PDGF signaling attenuates radiation-induced pulmonary fibrosisLong-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial.Impaired phosphorylation of JAK2-STAT5b signaling in fibroblasts from uremic children.The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.IL-22 sustains epithelial integrity in progressive kidney remodeling and fibrosis
P2860
Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease.
@en
Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease.
@nl
type
label
Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease.
@en
Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease.
@nl
prefLabel
Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease.
@en
Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease.
@nl
P2093
P2860
P356
P1476
Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease
@en
P2093
Daniel Landau
Debbie Wiezel
Leonid Kachko
Mohammed Hani Assadi
Ralph Rabkin
Yael Segev
P2860
P304
P356
10.1093/NDT/GFU003
P407
P50
P577
2014-01-23T00:00:00Z